Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture-Reference-Cited by-同舟云学术

Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture

Published:1991-11 Issue:3 Volume:35 Page:180-186
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Hung Li-Fang,Brumbaugh Amy E.,Bhatia Gulshan,Marion Patricia L.,Hung Paul P.,Norbeck Daniel W.,Plattner Jacob J.,Robinson William S.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference10 articles.

1. Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus

2. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

3. Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis

4. Taxonomic Classification of Human Hepatitis B Virus

5. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral chemotherapy for the treatment of hepatitis b virus infections;Gastroenterology;2000-02

2. Sensitivity of l-(-)2′,3′-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues;Biochemical Pharmacology;1999-06

3. New therapeutic strategies in the treatment of hepatitis B virus infection;Expert Opinion on Investigational Drugs;1999-03

4. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase;Antimicrobial Agents and Chemotherapy;1997-12

5. Recent developments in the treatment of chronic hepatitis B virus infection;Expert Opinion on Investigational Drugs;1995-02